The current and future role of nanovaccines in HIV-1 vaccine development
Christopher P. Karch, Gary R. Matyas
Abstract
: Nanovaccines are an area that is ripe for further exploration in HIV-1 vaccine field. Not only are nanovaccines capable of carrying and presenting antigens in native-like conformations, but they have also repeatedly been shown to increase immunogenicity over recombinant antigens alone. Only through further research can the true role of nanovaccines in the development of an efficacious HIV-1 vaccine be established.
Topics & Concepts
ImmunogenImmunogenicityVirologyHIV vaccineAntigenAntibodyPopulationBiologyVirusNeutralizing antibodyHuman immunodeficiency virus (HIV)ImmunologyMonoclonal antibodyMedicineVaccine trialEnvironmental healthHIV Research and TreatmentImmunotherapy and Immune ResponsesMonoclonal and Polyclonal Antibodies Research